27Background: The gut microbiota is known to influence virtually all facets of human health.
28Recent work has highlighted a potential role for the gut microbiota in neurological health 29 through the microbiome-gut-brain axis. Microbes can influence the brain both directly and 30 indirectly; through neurotransmitter production, induction of host immunomodulators, or 31 through the release or induction of other microbial or host molecules.
32Methods: Here we used mass spectrometry imaging (MSI), a label-free imaging tool, to map 33 the molecular changes that occur in the murine gut and brain in germ-free, antibiotic-treated 34 and control mice.
35Results: We determined the spatial distribution and relative quantification of 36 neurotransmitters and their precursors across brain and gut sections in response to the 37 microbiome. Using untargeted MSI of small molecules, we detected a significant change in 38 the levels of four identified metabolites in the brains of germ-free animals compared to 39 controls; vitamin B5, 3-hydroxy-3-methylglutaric acid, 3-methyl-4-
40(trimethylammonio)butanoate and 4-(trimethylammonio)pentanoate. However, antibiotic 41 treatment induced no significant changes in these metabolites in the brain after one week of 42 treatment.
43Conclusions: This work exemplifies the utility of MSI as a tool in determining the spatial 44 distribution and quantification of bacterial and host metabolites in the gut and brain whilst also 45 offering the potential for discovery of novel mediators of microbiome-gut-brain axis 46 communication.47 48 49 50 Background 51Deciphering the complex bi-directional communication across the microbiome gut brain 52 (MGB) axis remains a challenging prospect. The composition and stability of the gut 53 microbiome is now proposed to be a significant contributor to human health with changes in 54 its composition suggested as a contributing factor in a number of neurological conditions.
55Diverse human neurological disorders, ranging from autism spectrum disorders (ASDs) and 56 attention-deficit/hyperactivity disorder (ADHD) to Alzheimer's and Parkinson's disease, have 57 linked gastrointestinal abnormalities or changes in the gut microbiome (1-6). Similarly, 58 altered levels of certain bacterial species in the gut have been linked with depression (7, 8).
59Despite the deficiencies of germ free (GF) animal models, their use for investigating links 60 between the gut microbiota and the brain have proved informative and are helping to uncover 61 the influence of bacteria on neurotransmitter levels alongside other bacterial and host 62 metabolites. Their neuro-developmental abnormalities including increased blood-brain-barrier 63 (BBB) permeability, alterations in abundance and maturity of microglia cells, and reduced 64 myelination (9-11) have been well documented but their use, alongside antibiotic treated 65 (ABX) mice, have provided further evidence that supports the importance of a stable and 66 healthy gut microbiota in maintaining normal cognitive function and developm...